Introduction
It has been suggested that a state of increased local fibrinolytic activity in the uterus may be a possible cause of functional menorrhagia (Nilsson and Bjorkman, 1965) . The diagnosis of local fibrinolysis, however, has been presumptive, being based on the finding of diminished menstrual loss following therapeutic administration of inhibitors of fibrinolysis (Nilsson and Rybo, 1965; Vermylen et al., 1968) . A recent approach to the study of in-vivo fibrinolytic activity has been the measurement of the concentration of fibrin degradation products (F.D.P.) in the systemic blood . It is known that the uterus is a site of fibrinolytic activity and that F.D.P. are released into the uterine venous blood both in the nonpregnant state and during pregnancy (Mackay et al., 1967; Basu and Jeffcoate, 1969; Prentice et al., 1969 With the subject at rest 5 ml. of blood was obtained from an antecubital vein with minimum venous occlusion and collected in 500 kallikrein inactivating units (K.I.U.) of aprotinin (Trasylol). The serum was separated after incubating the clotted blood at 370 C. for one hour, and one-tenth of its volume of thrombin solution (100 units/ml.) was added to remove residual fibrinogen.
The serum was adsorbed overnight with 1/5 volume of packed formolized sheep red blood cells at 40 C. The concentrations of F.D.P. were determined by the haemagglutination inhibition method (Merskey et al., 1966) Ratnoff and Menzie (1951) . The sensitivity of the assay method was 0-5-0.6 ,ug./ml.
Results
In all three groups there were only slight changes in the mean levels of F.D.P. from week to week during the intermenstrual phase, but during the menstrual period the levels were higher (Table I) . Women with menorrhagia appeared to 98Ri0-4(n =55) 3-5 -0 7 (n= 18) 3.4 -0-4 (n =35) 4-7 ±04 (n =41) 2* 8-7d-11(n =14) 5-2+0 9(n =16) 3-6+0 5(n =22) 3-7±0 4(n =26) 3 18 5±1-8(n =20) 10-9±2 2(n =16) 12 3d-15(n= 19) 9 3+19(n=20) *These do not include women complaining of menorrhagia. A consideration of the results on blood obtained from healthy women (group 1) and from gynaecological patients without disturbed menstrual function (group 2) showed no appreciable difference between the groups (Table II) . The results on blood obtained from these two groups of women and those from women with menorrhagia are compared in The demonstration of an anticoagulant effect (which could be neutralized by protamine sulphate) in the blood of menstruating women by Rumbolz et al., in 1952, when the existence of F.D.P. was unknown, is of interest. They demonstrated that the concentration of the anticoagulant in the blood was higher dcuring menstruation than in the intermenstrual phase and was also higher in women who had had abnormal uterine haemorrhage (including menorrhagia) than in women with normal menstrual loss. It is known that F.D.P. have anticoagulant properties which can be neutralized by protamine sulphate (Vreeken et al., 1966) .
If it is assumed that increased concentrations of F.D.P. in the blood during menstruation result from excessive fibrinolytic activity, the latter is likely to be limited to the circulation of one or more organs as a local phenomenon. This is because fibrinolytic activity of the systemic blood is not increased during menstruation (Beller et al., 1964) . Mackay et al. (1967) produced evidence to suggest that F.D.P. may be released into the uterine venous system (and indirectly into the systemic blood). They thought that this may be a function of the vascularity of the organ, presumably because vascular endothelium is a source of plasminogen activator (Kwaan and Astrup, 1967) . Increased vascularity of the uterus during menstruation may therefore lead to the release of a large quantity of F.D.P. from the uterus into the systemic circulation.
Other observations suggest that fibrinolytic activity in the uterus may be increased during menstruation. Fibrinolytic activity of endometrial homogenates in saline was found to be significantly higher during menstruation than in the premenstrual phase (Rybo, 1966) . The concentrations of plasminogen activator in the endometrium is known to undergo cyclical variations, the maximum concentration being reached during the premenstrual period (Rybo, 1966) . It is possible that the premenstrual period represents a storage phase, and that during menstruation a large amount of activator is released into the uterine circulation. This results in a lower concentration of activator in the endometrium during the regenerative phase. Thus it is reasonable to assume that alterations in the serum concentration of F.D.P. throughout the menstrual cycle may be due, at least in part, to alterations in the local fibrinolytic activity in the uterus. Increased levels of F.D.P. during menstruation may also be linked with intravascular and extravascular deposits of fibrin present in the menstrual endometrium (Salvatore, 1969) . These deposits probably stimulate secondary fibrinolytic activity and release a large quantity of F.D.P.
The exact relation between menorrhagia and increased local fibrinolytic activity in the uterus is not certain. Though local fibrinolytic activity is considered to be a cause of menorrhagia (Nilsson and Bjorkman, 1965) , it is possible that widespread endometrial necrosis and hypoxia associated with increased menstrual bleeding may result in increased local fibrinolytic activity (Clarke and Cliffton, 1962) . Alternatively, both menorrhagia and increased local fibrinolytic activity may originate from a common mechanism such as increased vascularity of the uterus or altered activity of steroid hormones. The results reported here emphasize the need for further studies in this field. 
